Cencora, Inc.: Form 10-Q for the period ended Mar 31, 2019
Filed with the SEC on May 2, 2019 and accepted by EDGAR at May 2, 2019, 14:18 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-01-01 to 2019-03-31 | $43.32bn | us-gaap:Revenues |
| Revenue | 6 months2018-10-01 to 2019-03-31 | $88.71bn | us-gaap:Revenues |
| Cost of revenue | 3 months2019-01-01 to 2019-03-31 | $41.89bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2018-10-01 to 2019-03-31 | $85.99bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2019-01-01 to 2019-03-31 | $1.42bn | us-gaap:GrossProfit |
| Gross profit | 6 months2018-10-01 to 2019-03-31 | $2.72bn | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2019-01-01 to 2019-03-31 | $628.0m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2018-10-01 to 2019-03-31 | $1.28bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-01-01 to 2019-03-31 | $47.6m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2018-10-01 to 2019-03-31 | $525.4m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2019-01-01 to 2019-03-31 | −$9.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2018-10-01 to 2019-03-31 | $31.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-01-01 to 2019-03-31 | $27.1m | us-gaap:NetIncomeLoss |
| Net income | 6 months2018-10-01 to 2019-03-31 | $420.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-01-01 to 2019-03-31 | $0.13 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2018-10-01 to 2019-03-31 | $1.97 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-01-01 to 2019-03-31 | $0.13 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2018-10-01 to 2019-03-31 | $1.99 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-01-01 to 2019-03-31 | 212,563,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2018-10-01 to 2019-03-31 | 213,275,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2018-10-01 to 2019-03-31 | $1.10bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2018-10-01 to 2019-03-31 | $161.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2018-10-01 to 2019-03-31 | $170.4m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 6 months2018-10-01 to 2019-03-31 | $348.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2019-03-31 | $27.62bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-03-31 | $38.81bn | us-gaap:Assets |
| Current liabilities | At period end2019-03-31 | $29.21bn | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2019-03-31 | $4.01bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-03-31 | $164.8m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2019-03-31 | $2.92bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001140859-19-000015. Last ingested by Listed: Nov 15, 2026, 01:23 ET. Listed shows no prices and gives no investment advice.